Acp-204-012
ClinicalTrials.gov NCT07029581
Research payments
$665,853
Through program year 2025, $665,853 in research payments was reported against Acp-204-012, across 124 payments, paid by ACADIA Pharmaceuticals Inc.
- Paid by
- ACADIA Pharmaceuticals Inc
- ClinicalTrials.gov
- NCT07029581
By program year
1 row| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | Research | $665,853 | 124 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Mohammad Asim Nisar Okeechobee, FL Named on 30 payments
- Gil Fernandez-Yera Miami, FL Named on 25 payments
- Angel Carrasco Miami, FL Named on 20 payments
- Alexander Pushka Hollywood, FL Named on 15 payments
- Christopher Galloway Melbourne, FL Named on 5 payments
- Craig Curtis Kissimmee, FL Named on 5 payments
- Mustafa Zaidi Richmond, TX Named on 4 payments
- Ka Loong Au Kansas City, KS Named on 3 payments
- David Weisman Abington, PA Named on 1 payment
- Kevin Klos Tulsa, OK Named on 1 payment
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.